Clinical Trial: A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555340) titled 'A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B' on April 21.

Brief Summary: This study is a multicenter, ambidirectional cohort real-world study initiated by the First Affiliated Hospital of Zhengzhou University, aiming to evaluate the efficacy and safety of Pradefovir Mesylate Tablets in the treatment of chronic hepatitis B (CHB).

Study Start Date: Dec. 30, 2024

Study Type: OBSERVATIONAL

Condition: HEPATITIS B CHRONIC

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Juan Li

Information provided by (Responsible Party): Juan Li, The First Affiliated Hospi...